Abstract:The incidence rate and mortality of hypertension increase every year. Hypothalamic paraventricular nucleus (PVN) plays a critical role on the pathophysiology of hypertension. It has been demonstrated that the imbalance of neurotransmitters including norepinephrine (NE), glutamate (Glu) and γ-aminobutyric acid (GABA) are closely related to sympathetic overactivity and pathogenesis of hypertension. N-methyl-D-aspartate receptor (NMDAR), consisting of GluN1 and GluN2 subunits, is considered to be a glutamate-gated ion channel, which binds to Glu, and activates neuronal activity. Studies have found that the synthesis of respiratory chain enzyme complex was affected and mitochondrial function was impaired in spontaneously hypertensive rats (SHR), further indicating that mitochondria is associated with hypertension. Nuclear respiratory factor 1 (Nrf1) is a transcription factor that modulates mitochondrial respiratory chain and is related to GluN1, GluN2A, and GluN2B promoters. However, the brain mechanisms underlying PVN Nrf1 modulating sympathoexcitation and blood pressure during the development of hypertension remains unclear. In this study, an adeno-associated virus (AAV) vector carrying the shRNA targeting rat Nrf1 gene (shNrf1) was injected into bilateral PVN of male rats underwent two kidneys and one clip to explore the role of Nrf1 in mediating the development of hypertension and sympathoexcitation. Administration of shNrf1 knocked down the expression of Nrf1 and reduced the expression of excitatory neurotransmitters, increased the expression of inhibitory neurotransmitters, and reduced the production of reactive oxygen species (ROS), and attenuated sympathoexcitation and hypertension. The results indicate that knocking down Nrf1 suppresses sympathoexcitation in hypertension by reducing PVN transcription of NMDAR subunits (GluN1, GluN2A, and GluN2B), rebalancing PVN excitatory and inhibitory neurotransmitters, inhibiting PVN neuronal activity and oxidative stress, and attenuating sympathetic activity.

Advances in research on the central mechanism of hypertension

The Regulatory Effect of the Paraventricular Nucleus on Hypertension

PVN microglia via P2Y<sub>12</sub>transmit hemodynamic signal to promote sympathetic excitation in hypertension

PVN microglia via P2Y12 transmit hemodynamic signal to promote sympathetic excitation in hypertension

Brain Microglial Cytokines in Neurogenic Hypertension

Microglia, autonomic nervous system, immunity and hypertension: Is there a link?

Brain Transforming Growth Factor-Beta Resists Hypertension Via Regulating Microglial Activation

Microglial‐neuronal Interactions in the Paraventricular Nucleus (PVN): a Potential Mechanism Underlying Neurogenic Hypertension

Microglia Participate in Neurogenic Regulation of Hypertension

Construction and analysis of the protein-protein interaction network related to essential hypertension

Advances in research on the central mechanism of heart failure

Research Progress of Immunity Mechanism in Hypertension

Research Progress on Refractory Hypertension in Traditional Chinese Medicine

Advances in Pathogenesis and Treatment of Essential Hypertension

A neural perspective on the treatment of hypertension: the neurological network excitation and inhibition (E/I) imbalance in hypertension

Effects of Nrf1 in Hypothalamic Paraventricular Nucleus on Regulating the Blood Pressure During Hypertension

Emerging topics on basic research in hypertension: interorgan communication and the need for interresearcher collaboration

The Central Mechanism of Prehypertensive Rats Induced by High Salt Intake

Progress of drug therapy and target organs protection in hypertension

Impaired Hypothalamic Regulation of Sympathetic Outflow in Primary Hypertension

Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions